Christopher James Frankenfield, CFO: Xilio Therapeutics XLO Sell · Filed 01/05

Trade details

Type: Insider sale
Amount: $4,499.2
Shares · price: 7,030 sh · $0.64 a share
Held after: 24,766 sh
Stock: Xilio Therapeutics XLO
Person: Christopher James FrankenfieldCFO
Trade date: 26/01/02
Filed: 26/01/05
Days to filing: 3 days

Sold 22.1% of holdings

Share of holding sold: 22.1%

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/03~02/01

Christopher James Frankenfield's recent trades

Christopher James FrankenfieldCFO
Sell10b5-1 planXilio Therapeutics
Sell10b5-1 plan
Xilio Therapeutics
XLO
$6,815
6,954 sh
$6,815
Filed 25/01/03
Traded 25/01/02

Christopher James Frankenfield, CFO — sold $4,499 of Xilio Therapeutics XLO · 22.1% of holdings · 10b5-1 plan | Whalegun